Nonprofit Enduring Hearts announces partnership with Shop2Give fundraising
by MDJ staff
July 19, 2014 10:47 PM | 2990 views | 0 0 comments | 34 34 recommendations | email to a friend | print

Enduring Hearts, a Marietta-based nonprofit organization that awards operating grants to established members of academic staff at universities, transplant centers and research institutes for research projects in organ transplantation, has partnered with Shop2Give, a new fundraising solution that captures revenue from supporters’ online purchases, in-store mobile transactions and mobile donations. Enduring Hearts will earn an average of 2 to 3 percent on every purchase at no extra cost for Enduring Hearts or charity supporters.

“This innovative program will not only increase our ability to fund additional research, it will also increase public awareness about the need for advancement in the science of organ transplantation,” said Patrick Gahan, director and treasurer of Enduring Hearts.

With this new partnership, Enduring Hearts now opens up submissions for new grant applicants. While Enduring Hearts funds research that increases the longevity of organ transplants for all ages, the foundation primarily gives priority to research with pediatric benefits, especially with regards to pediatric heart transplant recipients.

“Enduring Hearts aims to promote research and development by offering grants for early stage projects that have the potential to lead to major breakthroughs in the field of pediatric heart transplantation,” said William Mahle, MD, professor of Pediatrics at Emory University and medical director of Clinical Research and Heart Transplant Program at Children’s Healthcare of Atlanta. “It is anticipated that studies funded by Enduring Hearts will lead to larger scale projects funded by extramural agencies such as the National Institutes of Health or American Heart Association.”

The Enduring Hearts Scientific Advisory Committee will make their grant selections by middle of September, based on the areas of scientific interest listed below:

Technology Application: Development of new technologies or applications thereof that would improve the care of transplant patients and thereby impact outcomes;

Transplant Immunology: Research and development of novel immunotherapies, identification of novel targets, improving the side effect profiles of these agents, as well as better monitoring and measurement of immunosuppression;

Organ Matching: Strategies and innovations that would allow better organ matching and allocation;

Medication Compliance: Strategies to improve medication compliance, especially in adolescent patients and young adults; and

Education: Improving patient and family education related to transplantation.

Projects outside of these areas will be considered based on merit and potential impact. For projects that pertain to technology and applications, there will be no transfer of intellectual property to the organization. However, any clarifications or exceptions deemed appropriate, on an individual case basis, will be a part of the final grant approval.

For more information, contact Sean Bell at 1 (310) 426-9900 or or visit

Comments-icon Post a Comment
No Comments Yet
*We welcome your comments on the stories and issues of the day and seek to provide a forum for the community to voice opinions. All comments are subject to moderator approval before being made visible on the website but are not edited. The use of profanity, obscene and vulgar language, hate speech, and racial slurs is strictly prohibited. Advertisements, promotions, and spam will also be rejected. Please read our terms of service for full guides